Biosurgery refers to the surgical procedure that uses various artificial & natural surgical products. These products are used to isolate the wound and also prevent the blood loss by absorbing fluids & closing the wound. Implementation of these types of products helps with the problems associated with surgery and will help reduce the time after treatment.
As per analysis, “Global Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Region: Trend Outlook and Growth Opportunity” the key companies operating in the global biosurgery market include Integra Lifesciences Holdings Corporation, Becton, Dickinson and Company (C.R. Bard), Sanofi S.A., B. Braun Melsungen AG, Betatech Medical, Johnson & Johnson, Baxter International, Inc., CSL Limited, Pfizer, Inc., CryoLife Inc., Stryker Corporation, Medtronic PLC, Hemostasis LLC and among others. Owing to intense market competition, major market players are increasingly focusing on expanding their geographic presence in fast-growing markets and strengthening their ability to compete in the market by acquiring smaller companies with desired technology capabilities or geographic footprint.
Based on product type, biosurgery market can be bifurcated as soft-tissue attachment (synthetic mesh/patch and natural & biological mesh/patch), hemostatic agents, surgical sealants & adhesives (synthetic surgical sealing agents and natural surgical sealing agents), bone-graft substitutes (bone morphogenetic proteins, demineralized bone matrix, synthetic graft extender and cell-based matrices), staple line reinforcements, and adhesion barriers (synthetic adhesion barriers and natural adhesion barriers). Based on source type, market can be bifurcated as synthetic products and natural/biological products. In addition, based on application, market can be bifurcated as cardiovascular surgery, orthopedic surgery, gynecological surgery, neurological surgery, general surgery and other applications.
The biosurgery market is driven by rise in need for effective blood loss management in patients, followed by strong focus on research & development (R&D) leading to the launch of technologically advanced products, rise in awareness about biosurgical procedures & products and increase in volume of surgeries & growth in prevalence of severe trauma injuries. Apart from this, stringent regulatory framework and high price of biosurgery products along with rise in cost of surgical procedures may impact the market. Moreover, growth in adoption of advanced biosurgery products in emerging markets, rise in use of combination materials to enhance product efficacy and growth in adoption of adhesive dentistry procedures are leading opportunities for market. Furthermore, growth in preference for gelatin-based adhesives & hydro-gels in surgical procedures, increase in focus on organic growth strategies and rise in use of nanotechnology for developing next-generation adhesives are major trend for global market.
Based on regional analysis, the North-America is a leading region in global biosurgery market owing to presence of highly developed healthcare system, favorable reimbursement policies for biosurgery products, significant number of prominent vendors, and rise in prevalence of traumatic injuries & lifestyle disorders and increase in number of healthcare settings across the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to increase in geriatric population, rise in need to manage the blood loss effectively coupled with growth in number of surgical procedures over the forecast period. It is predicted that future of the global biosurgery market will be bright caused by growth in healthcare expenditure during the forecast period.
For More Information, click on the link below:-
Global Biosurgery Market Research Report
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
